PPD recently opened a new central lab facility in Singapore, where the CRO has had an office for more than 10 years. 

The new lab will expedite delivery of lab data, PPD said, reducing the cost of customized laboratory services for customers conducting work in southeast Asia.

"Expanding our global central lab services into Singapore demonstrates our commitment to deliver high quality specimens and laboratory results for our clients in a growing biopharmaceutical market," said PPD’s Steve Lobel, vice president of global laboratory operations, in a statement. "We can expedite delivery of lab data through reduced transportation and shipping time at better logistics costs for our clients."

PPD’s Singapore office provides a range of clinical development services, including clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs.

The company has other global central laboratories in Brussels, Belgium; Highland Heights, Ky.; and Beijing, China.